Growth hormone and pulmonary disease. Metabolic effects in patients receiving parenteral nutrition

U. Suchner, M. M. Rothkopf, G. Stanislaus, D. H. Elwyn, V. Kvetan, J. Askanazi

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Six severely malnourished patients with chronic obstructive pulmonary disease were maintained for 3 days with infusions of 5% dextrose in water followed by 12 days of eucaloric total parenteral nutrition. On days 8 through 11, they received 30 μg/d of growth hormone and twice this amount on days 11 through 15. Growth hormone had no significant effects on the plasma concentration of glucose, cortisol, or glucagon but caused a 50% increase in insulin and a 250% increase in somatomedin C concentrations. A positive nitrogen balance of 2 g/d due to growth hormone was probably mediated by insulin. Growth hormone-induced increases in energy expenditure and fat oxidation and decrease in glucose oxidation cannot be accounted for by insulin. The ability of growth hormone to improve nitrogen balance may be particularly important for malnourished patients with chronic obstructive pulmonary disease who, because of their pulmonary insufficiency, are intolerant of excess nutrients.

Original languageEnglish (US)
Pages (from-to)1225-1230
Number of pages6
JournalArchives of Internal Medicine
Volume150
Issue number6
DOIs
StatePublished - Jun 29 1990
Externally publishedYes

Fingerprint

Parenteral Nutrition
Lung Diseases
Growth Hormone
Insulin
Glucose
Chronic Obstructive Pulmonary Disease
Nitrogen
Total Parenteral Nutrition
Glucagon
Insulin-Like Growth Factor I
Energy Metabolism
Hydrocortisone
Fats
Food
Lung
Water

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Suchner, U. ; Rothkopf, M. M. ; Stanislaus, G. ; Elwyn, D. H. ; Kvetan, V. ; Askanazi, J. / Growth hormone and pulmonary disease. Metabolic effects in patients receiving parenteral nutrition. In: Archives of Internal Medicine. 1990 ; Vol. 150, No. 6. pp. 1225-1230.
@article{44c71aa13b414e1480bec05e6092b6da,
title = "Growth hormone and pulmonary disease. Metabolic effects in patients receiving parenteral nutrition",
abstract = "Six severely malnourished patients with chronic obstructive pulmonary disease were maintained for 3 days with infusions of 5{\%} dextrose in water followed by 12 days of eucaloric total parenteral nutrition. On days 8 through 11, they received 30 μg/d of growth hormone and twice this amount on days 11 through 15. Growth hormone had no significant effects on the plasma concentration of glucose, cortisol, or glucagon but caused a 50{\%} increase in insulin and a 250{\%} increase in somatomedin C concentrations. A positive nitrogen balance of 2 g/d due to growth hormone was probably mediated by insulin. Growth hormone-induced increases in energy expenditure and fat oxidation and decrease in glucose oxidation cannot be accounted for by insulin. The ability of growth hormone to improve nitrogen balance may be particularly important for malnourished patients with chronic obstructive pulmonary disease who, because of their pulmonary insufficiency, are intolerant of excess nutrients.",
author = "U. Suchner and Rothkopf, {M. M.} and G. Stanislaus and Elwyn, {D. H.} and V. Kvetan and J. Askanazi",
year = "1990",
month = "6",
day = "29",
doi = "10.1001/archinte.150.6.1225",
language = "English (US)",
volume = "150",
pages = "1225--1230",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "6",

}

Growth hormone and pulmonary disease. Metabolic effects in patients receiving parenteral nutrition. / Suchner, U.; Rothkopf, M. M.; Stanislaus, G.; Elwyn, D. H.; Kvetan, V.; Askanazi, J.

In: Archives of Internal Medicine, Vol. 150, No. 6, 29.06.1990, p. 1225-1230.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Growth hormone and pulmonary disease. Metabolic effects in patients receiving parenteral nutrition

AU - Suchner, U.

AU - Rothkopf, M. M.

AU - Stanislaus, G.

AU - Elwyn, D. H.

AU - Kvetan, V.

AU - Askanazi, J.

PY - 1990/6/29

Y1 - 1990/6/29

N2 - Six severely malnourished patients with chronic obstructive pulmonary disease were maintained for 3 days with infusions of 5% dextrose in water followed by 12 days of eucaloric total parenteral nutrition. On days 8 through 11, they received 30 μg/d of growth hormone and twice this amount on days 11 through 15. Growth hormone had no significant effects on the plasma concentration of glucose, cortisol, or glucagon but caused a 50% increase in insulin and a 250% increase in somatomedin C concentrations. A positive nitrogen balance of 2 g/d due to growth hormone was probably mediated by insulin. Growth hormone-induced increases in energy expenditure and fat oxidation and decrease in glucose oxidation cannot be accounted for by insulin. The ability of growth hormone to improve nitrogen balance may be particularly important for malnourished patients with chronic obstructive pulmonary disease who, because of their pulmonary insufficiency, are intolerant of excess nutrients.

AB - Six severely malnourished patients with chronic obstructive pulmonary disease were maintained for 3 days with infusions of 5% dextrose in water followed by 12 days of eucaloric total parenteral nutrition. On days 8 through 11, they received 30 μg/d of growth hormone and twice this amount on days 11 through 15. Growth hormone had no significant effects on the plasma concentration of glucose, cortisol, or glucagon but caused a 50% increase in insulin and a 250% increase in somatomedin C concentrations. A positive nitrogen balance of 2 g/d due to growth hormone was probably mediated by insulin. Growth hormone-induced increases in energy expenditure and fat oxidation and decrease in glucose oxidation cannot be accounted for by insulin. The ability of growth hormone to improve nitrogen balance may be particularly important for malnourished patients with chronic obstructive pulmonary disease who, because of their pulmonary insufficiency, are intolerant of excess nutrients.

UR - http://www.scopus.com/inward/record.url?scp=0025325641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025325641&partnerID=8YFLogxK

U2 - 10.1001/archinte.150.6.1225

DO - 10.1001/archinte.150.6.1225

M3 - Article

C2 - 2112905

AN - SCOPUS:0025325641

VL - 150

SP - 1225

EP - 1230

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 6

ER -